Skip to main content
. 2023 Jun 26;14:1188431. doi: 10.3389/fimmu.2023.1188431

Table 5.

CD4+ polypositive T cells after stimulation with GI.4 and GII.4 VLPs expressed as Geometric Mean of the cell count at scheduled time points for each study group.

Time point
CD4+ polypositive Study group Parameter
95% CI
Day 1 Day 29 Day 57 Day 365
GI.4 Chiba 407 (1987) rNV-2v 50 µg Geomean* 22.2 337.9 457.6 114.9
95% CI 7.5 - 65.8 158.6 - 719.9 305.7 - 685.0 50.8 - 260.3
rNV-2v 150 µg Geomean 13.8 314.4 378.6 170.6
95% CI 4.4 - 43.3 247.8 - 399.1 286.5 - 500.3 87.9 - 331.0
Placebo Geomean 17.6 21.9 32.6 10.2
95% CI 5.6 - 55.9 7.8 - 61.8 13.1 - 81.1 3.3 - 32.0
GII.4 Aomori 2 (2006) rNV-2v 50 µg Geomean 56.6 585.3 459 133.2
95% CI 20.0 - 160.8 428.4 - 799.8 273.9 - 769.3 60.4 - 293.9
rNV-2v 150 µg Geomean 96.8 515.5 581.3 210.8
95% CI 42.7 - 219.2 379.3 - 700.5 437.4 - 772.5 96.9 - 458.5
Placebo Geomean 50 42.8 36.9 27.7
95% CI 18.2 - 137.2 16.5 - 110.8 13.0 - 105.0 10.3 - 74.6

CI, confidence interval; Geomean, geometric mean of the cell count.

*Geometric mean values are expressed as cell count (frequencies per million parent cells.